Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Mar 16;17(6):1728-39.
doi: 10.1093/emboj/17.6.1728.

Cooperative interaction of ets-1 with USF-1 required for HIV-1 enhancer activity in T cells

Affiliations

Cooperative interaction of ets-1 with USF-1 required for HIV-1 enhancer activity in T cells

M H Sieweke et al. EMBO J. .

Abstract

The distal enhancer region of the human immunodeficiency virus 1 (HIV-1) long terminal repeat (LTR) is known to be essential for HIV replication and to contain immediately adjacent E-box and Ets binding sites. Based on a yeast one-hybrid screen we have identified the E-box binding protein USF-1 as a direct interaction partner of Ets-1 and found that the complex acts on this enhancer element. The binding surfaces of USF-1 and Ets-1 map to their DNA-binding domains and although these domains are highly conserved, the interaction is very selective within the respective protein family. USF-1 and Ets-1 synergize in specific DNA binding as well as in the transactivation of reporter constructs containing the enhancer element, and mutations of the individual binding sites dramatically reduce reporter activity in T cells. In addition, a dominant negative Ets-1 mutant inhibits both USF-1-mediated transactivation and the activity of the HIV-1 LTR in T cells. The inhibition is independent of Ets DNA-binding sites but requires the Ets binding surface on USF-1, highlighting the importance of the direct protein-protein interaction. Together these results indicate that the interaction between Ets-1 and USF-1 is required for full transcriptional activity of the HIV-1 LTR in T cells.

PubMed Disclaimer

References

    1. J Virol. 1992 Apr;66(4):2514-8 - PubMed
    1. J Immunol. 1989 Dec 15;143(12):3956-60 - PubMed
    1. Genes Dev. 1990 Oct;4(10):1730-40 - PubMed
    1. Genes Dev. 1991 Apr;5(4):656-69 - PubMed
    1. J Virol. 1991 May;65(5):2436-44 - PubMed

Publication types

MeSH terms

Associated data